Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Taiko Pharmaceutical Co Ltd

+ Add to Watchlist

4574:JP

1,876.0 JPY 13.0 0.69%

As of 02:00:00 ET on 04/27/2015.

Snapshot for Taiko Pharmaceutical Co Ltd (4574)

Open: 1,885.0 Day's Range: 1,872.0 - 1,887.0 Volume: 43,100
Previous Close: 1,889.0 52wk Range: 1,325.0 - 2,531.6 1-Yr Rtn: +24.47%

Stock Chart for 4574

No chart data available.
  • 4574:JP 1,873.0
  • 1D
  • 1M
  • 1Y
1,889.0
Interactive 4574 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4574

Current P/E Ratio (ttm) 14.5280
Estimated P/E(03/2015) 15.6529
Relative P/E vs. TPX 0.7869
Earnings Per Share (JPY) (ttm) 129.1300
Est. EPS (JPY) (03/2015) 119.8500
Est. PEG Ratio -
Market Cap (M JPY) 25,477.58
Shares Outstanding (M) 13.58
30 Day Average Volume 126,397
Price/Book (mrq) 1.9348
Price/Sale (ttm) 2.4966
Dividend Indicated Gross Yield 0.80%
Cash Dividend (JPY) 15.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth 20.11%
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4574

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4574

Taiko Pharmaceutical Co Ltd. is a pharmaceutical company that manufactures and sells gastrointestinal pharmaceuticals and general use pharmaceutical products.

Hitoshi ShibataChairmanTakashi ShibataPresident
Tomosada YoshikawaSenior Managing DirectorAtsunori KatoDirector
More Company Profile & Key Executives for 4574

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil